Merus N v (MRUS) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MRUS Annual Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Merus N v adapts its cash strategy across cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2025)
9 Months
(Jun 30 2025) (Mar 31 2025) (Dec 31 2024) (Sep 30 2024)
Operating Activities
Income-95.52
Depreciation & amortization1.72
Amortization of Other Assets0.14
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation20.97
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction-2.17
Adjustments For Decrease Increase In Other Assets-
Adjustments For Increase Decrease In Trade And Other Payables-
Adjustments For Increase Decrease In Other Liabilities And Accurals-
Adjustments For Increase Decrease In Deferred Income-
Foreign Exchange Gain87.84
Debt And Equity Securities Unrealized Gain Loss-3.94
Non- Cash Customer Consideration-1.90
Income taxes0.40
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-16.91
Increase (Decrease) in Accounts Payable3.18
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-4.66
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-2.09
Other Working Capital-0.06
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-20.18
Discontinued operations0.00
Net Cash flow from Operating Activities-250.61
Investing Activities
Capital Expenditures-0.59
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities268.32
Payments to Acquire Marketable Securities-283.58
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-15.85
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock346.68
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-294.40
Payments For Share Issue Costs-
Proceeds From Collaboration Agreement-
Changes In Restricted Cash-
Payment Of Offering Costs-0.52
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents294.03
Capital Expenditures Incurred But Not Yet Paid0.37
Short Swing Profit Disgorgement-
Proceeds From Issuance Of Common Stock On Open Market-
Non Cash Issuance Of Stock Options-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities346.16
Effect of exchange rate on cash flow-5.50
Discontinued operations0.00
Free Cash Flow-251.20
Total Cash Flow74.20
4 historic quarters locked

Sign in to unlock the full Merus N v cash flow history.

About Merus N v Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-25-260700

Figures are derived from filed reports and may be restated. Historical data is subject to revision.